|
TSEN34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.159500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.943800E-03 |
| Normal-vs-Stage2 |
4.219600E-01 |
| Normal-vs-Stage3 |
5.639100E-03 |
| Normal-vs-Stage4 |
1.148190E-02 |
| Stage1-vs-Stage2 |
3.223200E-01 |
| Stage1-vs-Stage3 |
3.725400E-01 |
| Stage1-vs-Stage4 |
4.173400E-01 |
| Stage2-vs-Stage3 |
1.759050E-01 |
| Stage2-vs-Stage4 |
1.772360E-01 |
| Stage3-vs-Stage4 |
9.301800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.999870E-03 |
| Normal-vs-AfricanAmerican |
2.473800E-01 |
| Normal-vs-Asian |
5.199600E-04 |
| Caucasian-vs-AfricanAmerican |
4.988400E-01 |
| Caucasian-vs-Asian |
2.032400E-01 |
| AfricanAmerican-vs-Asian |
1.243410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.078330E-02 |
| Normal-vs-Female |
5.263800E-03 |
| Male-vs-Female |
7.012200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.896100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.582000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.131000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.135370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.853600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.338000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.355800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.655780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.510000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.709550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.647800E-01 |
| Classical-VS-Follicular |
5.417800E-04 |
| Classical-VS-Other |
5.269400E-01 |
| Classical-VS-Normal |
7.98820000000866E-05 |
| Tall-VS-Follicular |
1.641770E-01 |
| Tall-VS-Other |
8.855200E-01 |
| Tall-VS-Normal |
9.882100E-02 |
| Follicular-VS-Other |
5.466800E-01 |
| Follicular-VS-Normal |
8.418200E-01 |
| Other-VS-Normal |
6.238000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.712150E-02 |
| Normal-vs-N1 |
8.094300E-02 |
| N0-vs-N1 |
9.600000E-01 |
|
|
